These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27283175)

  • 1. iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer.
    Ma Y; Xiao T; Xu Q; Shao X; Wang H
    Front Med; 2016 Sep; 10(3):278-85. PubMed ID: 27283175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
    Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
    Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
    Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
    Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression analysis of leucine-rich PPR-motif-containing protein (LRPPRC), a candidate colorectal cancer biomarker identified by shotgun proteomics using iTRAQ.
    Nishio T; Kurabe N; Goto-Inoue N; Nakamura T; Sugimura H; Setou M; Maekawa M
    Clin Chim Acta; 2017 Aug; 471():276-282. PubMed ID: 28622966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
    de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
    J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of minute amount of colonic biopsies by enteroscopy sampling.
    Liu X; Xu Y; Meng Q; Zheng Q; Wu J; Wang C; Jia W; Figeys D; Chang Y; Zhou H
    Biochem Biophys Res Commun; 2016 Aug; 476(4):286-292. PubMed ID: 27230957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
    Bai Y; Wang J; Gao Z; Dai E
    Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
    Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
    J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.
    Qiao J; Fang CY; Chen SX; Wang XQ; Cui SJ; Liu XH; Jiang YH; Wang J; Zhang Y; Yang PY; Liu F
    Oncotarget; 2015 Oct; 6(30):29929-46. PubMed ID: 26338966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer.
    Sugihara Y; Taniguchi H; Kushima R; Tsuda H; Kubota D; Ichikawa H; Sakamoto K; Nakamura Y; Tomonaga T; Fujita S; Kondo T
    J Proteomics; 2012 Sep; 75(17):5342-55. PubMed ID: 22735596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
    Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
    J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation.
    Cui J; Cai Y; Hu Y; Huang Z; Luo Y; Kaz AM; Yang Z; Chen D; Fan X; Grady WM; Wang J
    Tumour Biol; 2016 Sep; 37(9):12477-12483. PubMed ID: 27333992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of ORM2 in the development of colorectal cancer.
    Zhang X; Xiao Z; Liu X; Du L; Wang L; Wang S; Zheng N; Zheng G; Li W; Zhang X; Dong Z; Zhuang X; Wang C
    PLoS One; 2012; 7(2):e31868. PubMed ID: 22363757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry.
    Jankova L; Chan C; Fung CL; Song X; Kwun SY; Cowley MJ; Kaplan W; Dent OF; Bokey EL; Chapuis PH; Baker MS; Robertson GR; Clarke SJ; Molloy MP
    Mol Biosyst; 2011 Nov; 7(11):2997-3005. PubMed ID: 21808808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.
    Yao L; Lao W; Zhang Y; Tang X; Hu X; He C; Hu X; Xu LX
    J Proteome Res; 2012 Jun; 11(6):3281-94. PubMed ID: 22506683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.